Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.06 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:47 AM EDT

Mosaic ImmunoEngineering (CPMV) EV to EBITDA (2013 - 2017)

Updated

Mosaic ImmunoEngineering's (CPMV) EV to EBITDA was 44053.10 for Q1 2018.

Analysis

Mosaic ImmunoEngineering (CPMV) EV to EBITDA (2013 - 2017) Analysis & Trends

Over the twelve months ended Aug 31, 2017, Mosaic ImmunoEngineering's EV to EBITDA came in at 43813.61; for FY2013, it came in at 19200.83.

  • The Q1 2018 figure ranks as the highest quarterly EV to EBITDA since Q2 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Mosaic ImmunoEngineering 441,423.27 352,385.27 -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2017 44,053.10
Feb 28, 2014 12,324.57
Nov 30, 2013 64,795.76
Aug 31, 2013 15,902.45
May 31, 2013 19,200.83
API Access

Mosaic ImmunoEngineering EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CPMV&period=max&api_key=YOUR_API_KEY